Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

SecurityADPT / Adaptive Biotechnologies Corporation
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in ADPT / Adaptive Biotechnologies Corporation

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Adaptive Biotechnologies Corporation (US:ADPT) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 2,104,414 shares of Adaptive Biotechnologies Corporation. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -100.00 0
2025-11-13 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 2,104,414 1,444,358 218.82 31,482 309.39 0.0367
2025-08-14 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 660,056 660,056 7,690 0.0094
2024-08-09 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 0 -121,185 -100.00 0 -100.00
2024-05-14 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 121,185 -2,113 -1.71 389 -35.60 0.0004
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 123,298 17,931 17.02 604 5.23 0.0007
2023-11-14 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 105,367 2,055 1.99 574 -17.17 0.0007
2023-10-27 2023-06-30 13F/A-2 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 103,312 15,781 18.03 693 -10.35 0.0008
2023-10-12 2023-06-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 103,312 15,781 693 0.0007
2023-08-14 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 103,312 15,781 693 0.0007
2023-06-01 2023-03-31 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 87,531 29,655 51.24 773 74.89 0.0009
2023-05-15 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 87,531 29,655 773 0.0007
2023-02-21 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 57,876 -18,796 -24.51 442 -20.07 0.0005
2022-11-14 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 76,672 -1,323 -1.70 553 -12.36 0.0007
2022-08-17 2022-06-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 77,995 -351 -0.45 631 -41.95 0.0007
2022-08-15 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 77,995 -351 631 0.0002
2022-05-16 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 78,346 3,546 4.74 1,087 -48.21 0.0008
2022-02-11 2021-12-31 13F Adaptive Biotechnologies COM 00650F109 74,800 12,344 19.76 2,099 -1.13 0.0017
2021-11-12 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 62,456 7,394 13.43 2,123 -5.64 0.0018
2021-08-13 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 55,062 4,553 9.01 2,250 10.62 0.0018
2021-05-14 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 50,509 10,847 27.35 2,034 -13.30 0.0029
2021-02-16 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 39,662 -3,308 -7.70 2,346 12.30 0.0034
2020-11-13 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 42,970 -3,151 -6.83 2,089 -6.36 0.0035
2020-08-11 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 46,121 3,871 9.16 2,231 90.03 0.0038
2020-05-15 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 42,250 11,697 38.28 1,174 28.45 0.0024
2020-03-18 2019-12-31 13F/A-2 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 30,553 30,553 914 0.0013
2020-02-28 2019-12-31 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 30,553 0 914 0.0013
2020-02-14 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 30,553 914 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.